Comparison of the effects of nitric oxide synthase, guanylate cyclase and potassium channel inhibition on vascular contractions in vitro in the rat

Journal of Autonomic Pharmacology

Volumn 19, Issue 5, 1999, Pages 263-266

  Abdullah, K ^a   Docherty, J R ^a  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; APAMIN; CHARYBDOTOXIN; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; GUANYLATE CYCLASE; GUANYLATE CYCLASE INHIBITOR; IBERIOTOXIN; METHYLENE BLUE; N(G) METHYLARGININE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; PROSTAGLANDIN F2 ALPHA;

ANIMAL TISSUE; ARTICLE; BLOOD VESSEL TONE; CONTROLLED STUDY; DRUG EFFECT; MALE; MESENTERIC ARTERY; NONHUMAN; RAT; SMOOTH MUSCLE; VASOCONSTRICTION;

ANALYSIS OF VARIANCE; ANIMALS; APAMIN; CHARYBDOTOXIN; DRUG COMBINATIONS; DRUG INTERACTIONS; ENZYME INHIBITORS; GUANYLATE CYCLASE; MALE; MESENTERIC ARTERIES; METHYLENE BLUE; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE SYNTHASE; OMEGA-N-METHYLARGININE; POTASSIUM CHANNEL BLOCKERS; RATS; RATS, WISTAR; VASOCONSTRICTION;

EID: 0033509734     PISSN: 01441795     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2680.1999.00145.x     Document Type: Article

References (23)

1. Abdullah, K., Cawley, T., Connolly, C., Ruiz, E. & Docherty, J.R. (1997). Comparison of the effects of nitric oxide synthase inhibition and guanylate cyclase inhibition on vascular contraction in vitro and in vivo in the rat. Naunyn-Schmiedeberg's Arch. Pharmacol., 356, 481-487.
2. Gnitro-L-arginine. Br. J. Pharmacol., 107, 616-621.
3. Bolotina, V., Najibi, S., Palacino, J.J., Pagano, P.J. & Cohen, R. (1994). Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature, 368, 850-853.
4. Brayden, J.E. (1990). Membrane depolarisation is a mechanism of endothelium-dependent cerebral vasodilation. Am. J. Physiol., 259, H668-H673.
5. Cawley, T., Breslin, E., Geraghty, J., Osborne, H. & Docherty, J.R. (1995). Investigations of the function of the vascular endothelium in portal hypertensive rats. Pharmacology, 51, 381-390.
6. Cocks, T.C. & Angus, J.A. (1991). Evidence that contractions of isolated arteries by L-NMMA and NOLA are not due to inhibition of basal EDRF release. J. Cardiovasc. Pharmacol., 17(Suppl. 3), S159-S164.
7. Corriu, C., Feletou, M., Canet, E. & Vanhoutte, P.M. (1996). Endothelium-derived factors and hyperpolarization of the carotid artery of the guinea-pig. Br. J. Pharmacol., 119, 959-964.
8. + is an endothelium-derived hyperpolarizing factor in rat arteries. Nature, 396, 269-272.
9. Feletou, M. & Vanhoutte, P.M. (1988). Endothelium-dependent hyperpolarisation of canine coronary smooth muscle. Br. J. Pharmacol., 93, 515-524.
10. Furchgott, R.F. & Zawadzki, J.V. (1980). The obligatory role of endothelial cells in the relaxation of arterial smooth muscle cells by acetylcholine. Nature, 288, 373-376.
11. Garland, C.J. & McPherson, G.A. (1992). Evidence that nitric oxide does not mediate the hyperpolarisation and relaxation to acetylcholine in the rat small mesenteric artery. Br. J. Pharmacol., 105, 429-435.
12. Garland, C.J., Plane, F., Kemp, B.K. & Cocks, T.M. (1995). Endothelium-dependent hyperpolarization: a role in the control of vascular tone. Trends Pharmacol. Sci., 16, 23-30.
13. Komori, K., Lorenz, R.R. & Vanhoutte, P.M. (1988). Nitric oxide, ACh and electrical properties of canine arterial smooth muscle. Am. J. Physiol., 255, H207-H212.
14. Martin, W., Furchgott, R.F., Villani, G.M. & Jothianandan, D. (1986). Depression of contractile responses in rat aorta by spontaneously released endothelium-derived relaxing factor. J. Pharmacol. Exp. Ther., 237, 529-538.
15. Mayer, B., Brunner, F. & Schmidt, K. (1993). Inhibition of nitric oxide synthesis by methylene blue. Biochem. Pharmacol., 45, 367-374.
16. Mulvany, M.J. & Warshaw, D.M. (1977). The active tension-length of vascular smooth muscle related to its cellular components. J. Gen. Physiol., 74, 85-104.
17. Palmer, R.M.J., Ferrige, A.G. & Moncada, S. (1987). Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature, 327, 524-526.
18. Plane, F., Holland, M., Waldron, G.J., Garland, C.J. & Boyle, J.P. (1997). Evidence that anandamide and EDHF act via different mechanisms in rat isolated mesenteric arteries. Br. J. Pharmacol., 121, 1509-1511.
19. Rees, D.D., Palmer, R.M.J., Schulz, R., Hodson, H.F. & Moncada, S. (1990). Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br. J. Pharmacol., 101, 746-752.
20. Taylor, S.G. & Weston, A. (1988). Endothelium-derived hyperpolarising factor, a new endogenous inhibitor from the vascular endothelium. Trends Pharmacol. Sci., 9, 272-274.
21. G-nitro-I-arginine and dephenyleneiodonium. Br. J. Pharmacol., 114, 194-202.
22. Wolin, M.S., Cherry, P.D., Rodenburg, J.M., Messina, E.J. & Kaley, G. (1990). Methylene blue inhibits vasodilatation of skeletal muscle arterioles to acetylcholine and nitric oxide via the extracellular generation of superoxide anion. J. Pharmacol. Exp. Ther., 254, 872-876.
23. Zygmunt, P.M. & Hogestatt, E.D. (1996). Role of potassiun channels in endothelium-dependent relaxation resistant to nitroarginine in the rat hepatic artery. Br. J. Pharmacol., 117, 1600-1606.